SCHEMBL4989502

SCHEMBL4989502

CCN1CCc2c(N)ncnc2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.42
RECQL P46063 1/20 0.42
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
KMT2A Q03164 2/20 0.38
HSD17B10 Q99714 2/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
PTK2B Q14289 1/20 0.38
ESR2 Q92731 1/20 0.38
LIMK1 P53667 1/20 0.37
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
PNMT P11086 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4985387 0.88 DRD2 (0.43) MAPTLIMK1PNMTLMNAF12
SCHEMBL4982902 0.85 ADORA2A (0.40) ALDH1A1MAPTHPGDLMNAADORA2A
SCHEMBL4989114 0.84 COMT (0.35) LIMK1ADORA2AADORA1
SCHEMBL4988741 0.84 KDR (0.44) MAPTLMNA
SCHEMBL4986780 0.83 PI4KA (0.39) KDM4EMEN1KMT2AMAPK1LIMK1
SCHEMBL8877237 0.82 PNMT (0.36) RAD52RECQLKDM4EMEN1ALDH1A1
SCHEMBL4985157 0.81 GRIA1 (0.39) MEN1KMT2ALIMK1CYP3A4
SCHEMBL4986063 0.81 LIMK1 (0.32) LIMK1ADORA2AADORA1
SCHEMBL4983874 0.80 PIK3CA (0.36) MEN1LIMK1HRH3
SCHEMBL4989371 0.79 LIMK1 (0.47) KDM4EMEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 RAD52 4542/4885RECQL 2182/4885KDM4E 4128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.